Trial Profile
A phase 2 study of oral enzastaurin HCl in patients with relapsed mantle cell lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzastaurin (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 28 Jul 2006 Status change
- 29 Aug 2005 New trial record.